See also this year's filing and all EDGAR filings for this company.
PDF Report 0001534120_2021_Avalo_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001534120, Avalo Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 26,005,344 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 15,994,263 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,755,712 |
| 4 | LiabilitiesCurrent | 15,224,936 |
| 5 | LiabilitiesNoncurrent | 1,878,395 |
| 6 | remainder_Liabilities | 2,090,395 |
| 7 | CostOfGoodsAndServicesSold | 300,199 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,417,450 |
| 9 | ResearchAndDevelopmentExpense | 32,192,335 |
| 10 | remainder_Expenses | 26,838,697 |
| 11 | remainder_Revenues | 6,698,615 |
| 12 | remainder_NetIncome | 6,550,294 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 43,755,319 |
| 1 | Liabilities | 19,193,726 |
| 2 | Expenses | 76,748,681 |
| 3 | Revenues | 6,698,615 |
| 4 | StockholdersEquity | 24,561,593 |
| 5 | NetIncome | -63,499,772 |
| 6 | ComprehensiveNetIncome | -63,499,772 |
| 7 | BaseVar | 76,473,318 |
| 8 | EconomicCapitalRatio | -0.675 |
Edgar->Model Mapping
Feature Distribution
Change over Time
